Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03001518 · ClinicalTrials.gov registry record
Immunologic Signatures Following Surgery for Pancreatic Cancer
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 33
- Enrollment target
NCT03001518 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 33 participants.
The verdict
NCT03001518 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The goal of this pilot study is to evaluate and describe the immunologic and overall outcomes of subjects who undergo routine pancreatectomy with or without irreversible electroporation (IRE) for pancreatic cancer. Immunologic markers in the blood will be measured at several time points before and after surgery to determine if surgical approach is associated with different immunologic responses. Secondary outcomes will include mortality and morbidity; operative time; blood loss and transfusion requirements; and oncologic outcomes such as: margin status, lymph node harvest, disease-free survival, and overall survival. Analysis of immune response will help the investigator determine whether to expand the pilot into a larger study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-05-04 |
| Est. Completion | 2023-01-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03001518
The ClinicalTrials.gov registry entry for NCT03001518 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03001518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03001518 about?
NCT03001518 is a clinical study titled "Immunologic Signatures Following Surgery for Pancreatic Cancer". The goal of this pilot study is to evaluate and describe the immunologic and overall outcomes of subjects who undergo routine pancreatectomy with or without irreversible electroporation (IRE) for pancreatic cancer. Immunologic markers in the blood will be measured at several time points before and a...
What is the current status of trial NCT03001518?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2017-05-04. Estimated completion is 2023-01-06.
Who is sponsoring clinical trial NCT03001518?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.